前列地尔联合厄贝沙坦治疗糖尿病肾病的临床疗效探讨
2020-10-12林冬阳
林冬阳


[摘要] 目的 研究帕罗西汀联合认知行为治疗在2型糖尿病合并抑郁症的药学价值。方法 选取2016年1月—2019年12月该院收治的2型糖尿病合并抑郁症60例作为该次研究对象,将60例患者随机分为常规组与观察组,常规组患者接受帕罗西汀治疗,观察组患者接受帕罗西汀联合认知行为治疗,对比两组患者比较两组患者治疗前后糖化血红蛋白和治疗后胆固醇、甘油三酯、BMI等指标,同时比较两组患者HAMD评分值和PHQ9量表。 结果 观察组患者治疗后糖化血红蛋白、HAMD评分值和PHQ9量表评分,差异有统计学意义(P<0.05),治疗后胆固醇、甘油三酯、BMI指标差异无统计学意义(P>0.05)。 结论 帕罗西汀联合认知行为治疗在2型糖尿病合并抑郁症的药学价值显著,可以考虑积极推广。
[关键词] 帕罗西汀;认知行为治疗;2型糖尿病;抑郁症;药学价值
[中图分类号] R587.1;R749.4 [文献标识码] A [文章编号] 1672-4062(2020)07(b)-0189-03
[Abstract] Objective To study the pharmaceutical value of paroxetine combined with cognitive behavior therapy in type 2 diabetes with depression. Methods Sixty patients with type 2 diabetes combined with depression admitted to our hospital from January 2016 to December 2019 were selected as the research object, and 60 patients were randomly divided into a conventional group and an observation group. Patients in the conventional group received paroxetine treatment. Patients in the observation group received paroxetine combined with cognitive behavioral therapy, compared with the two groups of patients before and after treatment, glycated hemoglobin and post-treatment cholesterol, triglyceride, BMI and other indicators, while comparing the HAMD score and PHQ9 scale of the two groups of patients. Results There were statistically significant differences in the glycated hemoglobin, HAMD score and PHQ9 scale after treatment in the observation group(P>0.05). There was no statistically significant significant difference in cholesterol, triglyceride and BMI indexes after treatment(P>0.05). Conclusion Paroxetine combined with cognitive behavioral therapy has significant pharmacological value in type 2 diabetes with depression, and it can be used for active promotion.
[Key words] Paroxetine; Cognitive behavioral therapy; Type 2 diabetes; Depression; Pharmaceutical value
该文就该院于2016年1月—2019年12月收治的2型糖尿病合并抑郁症60例作为该次研究对象,以此来研究帕罗西汀联合认知行为治疗在2型糖尿病合并抑郁症的药学价值,现报道如下。
1 资料与方法
1.1 一般资料
选取该院收治的2型糖尿病合并抑郁症60例作为该次研究对象,研究已经过医院伦理委员会的批准通过。将60例患者随机分为常规组(30例)与观察组(30例),其中常规组患者男女比例为23∶7;平均年龄为(48.64±4.43)岁。观察组患者男女比例为22∶8,平均年龄为(48.82±4.51)岁。两组基线资料对比,差异无统计学意义(P>0.05),能够进行比较。
1.2 纳入标准
①患者及患者家属均对该次研究知情,并自愿签署知情同意书;②均符合世界卫生组织制定的T2DM诊断标准;③符合中国抑郁障碍防治指南第二版2015诊断标准。……p>
